This content is machine translated Gastric carcinoma Ways of precision oncology New study data are fundamentally changing first-line treatment of metastatic gastric cancer. The ESMO on Air webinar on March 12, 2025 showed how biomarkers guide therapy selection and open up...…
View Post 0 min This content is machine translated Psoriasis in the Age of Precision Medicine Systemic Therapy for Patients with Comorbidities: What Is the Best Choice? ... Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post 8 min This content is machine translated Endometrial Cancer Immunological drivers and new therapeutic pathways Endometrial carcinoma is increasingly becoming the focus of modern tumor immunology as an immunologically characterized tumor disease. Molecular subtypes, microbiome interactions and a highly dynamic tumor immunological microenvironment are opening...…
View Post 6 min This content is machine translated Exercise for type 1 diabetes Cyclists and runners with an increased risk of hypoglycemia Physical activity is considered a key element in the treatment of type 1 diabetes. It improves cardiovascular fitness, metabolic control and quality of life. Nevertheless, the relationship between exercise and...…
View Post 4 min This content is machine translated Ozanimod for relapsing-remitting multiple sclerosis Signs of improved tolerability with prolonged treatment Ozanimod, a selective modulator of sphingosine-1-phosphate (S1P) receptors 1 and 5, has demonstrated efficacy in relapsing-remitting multiple sclerosis (RMS) in Phase 2 and 3 studies. At a dose of 0.92...…
View Post 5 min This content is machine translated Highlights from the AAD Annual Meeting Atopic Dermatitis: Interesting News on Drug Candidates in Phase III At the 2026 Annual Meeting of the American Academy of Dermatology (AAD), the latest study data on amlitelimab and rademikibart, among other topics, were presented during Late-Breaking Research sessions. The...…
View Post 8 min This content is machine translated When basal cell carcinomas prove difficult to treat Reaching the goal with innovative therapy strategies The further development of patient-oriented, function-preserving treatment strategies is an important concern of skin cancer research. For patients with advanced cutaneous basal cell carcinoma (BCC), there is a need for...…
View Post 3 min This content is machine translated Psoriasis Research: What's in the Pipeline? Highly selective oral TYK inhibitors in Phase III Envudeucitinib and Zasocitinib are oral, allosteric tyrosine kinase 2 (TYK2) inhibitors currently being evaluated in clinical trials for plaque psoriasis. The interim results presented during the Late-Breaking Research sessions at...…
View Post 3 min This content is machine translated Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy Remodeling can be counteracted through a proactive treatment strategy If certain key, evidence-based principles are followed, remission is now an achievable goal in asthma treatment. First, it is recommended to routinely supplement spirometry with a blood test to measure...…
View Post 6 min This content is machine translated Autoimmune Liver Diseases Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New? PPAR agonists as second-line therapy have proven effective in primary biliary cholangitis (PBC) not only in clinical trials but also in real-world settings, as recent research findings show. In primary...…
View Post 7 min This content is machine translated cSCC: Personalizing Treatment Strategies and Follow-up Care Plans Comprehensive risk stratification is no simple matter: what’s new? Cutaneous squamous cell carcinoma (cSCC) is currently the second most common type of skin cancer, and the number of cases continues to rise. While surgical resection alone is considered the...…
